Testosterone Solution
Product Images NDC 0591-2114

8 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Testosterone (NDC 0591-2114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Is Fortestosterone Topical Solution Is A Clear, Colorless, Single Phase Solution Containing 30 mg Of Testosterone In 1.5 mL Of Testosterone Topical Solution For Topical Administration Through The Axilla. The Active Pharmacologic Ingredient In Testosterone Topical Solution Is Testosterone. Testosterone, Usp Is A White To Practically White Crystalline Powder Chemically Described As 17-beta Hydroxyandrost-4-en-3-one. (Image 1)

The Structural Formula Is Fortestosterone Topical Solution Is A Clear, Colorless, Single Phase Solution Containing 30 mg Of Testosterone In 1.5 mL Of Testosterone Topical Solution For Topical Administration Through The Axilla. The Active Pharmacologic Ingredient In Testosterone Topical Solution Is Testosterone. Testosterone, Usp Is A White To Practically White Crystalline Powder Chemically Described As 17-beta Hydroxyandrost-4-en-3-one. (Image 1)
Chemical structure of testosterone showing its steroid nucleus with attached hydroxyl and ketone groups, molecular formula C19H28O2, and molecular weight 288.4.*
FDA Label Image

Figure 1: Mean (±sd) Serum Testosterone Concentrations On Day 7 In Patients Following Testosterone Topical Solution Once Daily Application Of 30 mg, 60 mg, Or 90 mg Of Testosterone (Image 2)

Figure 1: Mean (±sd) Serum Testosterone Concentrations On Day 7 In Patients Following Testosterone Topical Solution Once Daily Application Of 30 mg, 60 mg, Or 90 mg Of Testosterone (Image 2)
A line graph showing serum total testosterone concentration (ng/dL) over 24 hours after dose administration. The graph compares three dosage levels of testosterone: 30 mg, 60 mg, and 90 mg. Each dosage is represented by a distinct line with corresponding data points and error bars depicting variability at multiple time intervals.*
FDA Label Image

Figure 2: Mean (± Sd) Steady-state Serum Testosterone Concentrations On Day 120 (30, 60, 90 Or 120 mg Testosterone) In Patients Who Completed 120 Days (n=135) Of Testosterone Topical Solution Once Daily Treatment (Image 3)

Figure 2: Mean (± Sd) Steady-state Serum Testosterone Concentrations On Day 120 (30, 60, 90 Or 120 mg Testosterone) In Patients Who Completed 120 Days (n=135) Of Testosterone Topical Solution Once Daily Treatment (Image 3)
A line chart depicting serum total testosterone concentration (ng/dL) over time (hours) from dose administration. The y-axis shows testosterone levels ranging from 0 to 1400 ng/dL, with labeled upper and lower normal limits. The x-axis displays time from 0 to 24 hours. Data points connected by lines include error bars indicating variability at each time point.*
FDA Label Image

Actavis Laboratories Ut, Inc. (Image 4)

FDA Label Image

Pump (Image 5)

Pump (Image 5)
An instructional illustration showing the components of Testosterone topical solution packaging by Actavis Pharma, Inc. It labels the pump dispenser bottle containing 30 mg/1.5 mL strength, alongside the cap and the applicator cup used for topical application.*
FDA Label Image

3 (Image 6)

3 (Image 6)
An instructional illustration depicting two hands, one holding a bottle of Testosterone topical solution and the other holding a cap, demonstrating the process of opening the bottle. The bottle label shows the product name Testosterone and dosage strength 30 mg/1.5 mL.*
FDA Label Image

Remove The Cap And The Applicator Cup From The Pump. Then, Position The Nozzle Over The Applicator Cup And Depress The Pump Gently (see Figure 2). (Image 7)

Remove The Cap And The Applicator Cup From The Pump. Then, Position The Nozzle Over The Applicator Cup And Depress The Pump Gently (see Figure 2). (Image 7)
An instructional illustration showing a man applying a topical solution to his underarm area. The image depicts the correct application site, highlighting the armpit for administering the testosterone topical solution.*
FDA Label Image

1 (Image 8)

1 (Image 8)
Packaging label for Testosterone Topical Solution, 30 mg per pump actuation, containing 110 mL total solution. The label lists the manufacturer as Actavis Laboratories UT, Inc., with distribution by Actavis Pharma, Inc. It includes warnings about flammability, child safety, and instructions for topical use with an enclosed applicator. The label also specifies the active ingredient as Testosterone, USP, and inactive ingredients including ethanol and isopropyl alcohol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.